Medi-Caps submits standalone and consolidated un-audited financial results

11 Aug 2023 Evaluate

In continuation of letter no. MCL/BM/SE/2023-2024 dated 04th August, 2023 regarding intimation of Board of Directors meeting for consideration and approval of Standalone as well as Consolidated un-audited Financial Results for the Quarter ended on 30th June, 2023, Medi-Caps has informed that, in compliance with Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Board of Directors in their meetings held on 11th August, 2023 has considered and approved the following businesses: Un-audited Standalone and Consolidated Financial Results for the quarter ended on 30th June, 2023 and Limited Review Report by the Statutory Auditors of the Company for the un-audited Standalone and Consolidated quarter ended on 30th June, 2023. Further, it has also in process of filing the aforesaid un-audited financial results in the XBRL format within 24 hours from the conclusion of Board Meeting. The aforesaid results shall also be uploaded on the Company’s website www.medicaps.com and on the website of the Stock Exchange: at www.bseindia.com. Further, the extract of aforesaid results shall also be published in Hindi (vernacular) and widely circulated English Newspaper.

The above information is a part of company’s filings submitted to BSE.

Medi-Caps Share Price

33.62 -0.03 (-0.09%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
BASF India 4039.90
Tata Chemicals 773.85
SRF 2886.20
Pidilite Inds. 1474.70
Deepak Nitrite 1565.30
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×